The experimental study of ovarian carcinoma vaccine modified by human B7-1 and IFN- genes

Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.

Bernd Gänsbacher, Rajat Bannerji, Brian F. Daniels et al. · PubMed · 1990 · 413 citations

Life Sciences, Immunology, Oncology +17

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.

Andrew D. Luster, Philip Leder · The Journal of Experimental Medicine · 1993 · 411 citations · Full text

Medicine, Immunology, Oncology +17

Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice.

Sivasubramanian Baskar, Laurie H. Glimcher, N Nabavi et al. · The Journal of Experimental Medicine · 1995 · 185 citations · Full text

Medicine, Immunology, Oncology +17

Separation of tumor-infiltrating lymphocytes from tumor cells in human solid tumors

Theresa L. Whiteside, Sylvia Miescher, H. Robson MacDonald et al. · Journal of Immunological Methods · 1986 · 80 citations

Medicine, Immunology, Oncology +16

Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis

Peter T. Daniel, Arne Kroidl, S Cayeux et al. · The Journal of Immunology · 1997 · 78 citations

Life Sciences, Immunology, Oncology +17